MedPath

Tianjin Central Hospital Gynecology Obstetrics

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Effect of Early Lifestyle Intervention on Perinatal Outcomes in High-risk Women for Gestational Hyperglycemia

Not Applicable
Not yet recruiting
Conditions
GDM
First Posted Date
2025-08-26
Last Posted Date
2025-08-26
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Target Recruit Count
604
Registration Number
NCT07141173
Locations
🇨🇳

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China

Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics

Conditions
Gestational Diabetes
First Posted Date
2024-12-31
Last Posted Date
2025-05-31
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Target Recruit Count
600
Registration Number
NCT06753734
Locations
🇨🇳

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China

The Relationship Between Fetal Membrane Thickness and Fetal Chromosomal Aneuploidies

Recruiting
Conditions
Chromosome Aberrations
First Posted Date
2023-11-21
Last Posted Date
2023-11-21
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Target Recruit Count
300
Registration Number
NCT06141213
Locations
🇨🇳

Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, Tianjin, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.